Chinese Journal of Integrative Medicine

, Volume 22, Issue 6, pp 445–450 | Cite as

Antipyretic and anti-asthmatic activities of traditional Chinese herb-pairs, Ephedra and Gypsum

  • Fen Mei (梅 芬)
  • Xue-feng Xing (邢学锋)
  • Qing-fa Tang (汤庆发)
  • Fei-long Chen (陈飞龙)
  • Yang Guo (郭 阳)
  • Shuai Song (宋 帅)
  • Xiao-mei Tan (谭晓梅)
  • Jia-bo Luo (罗佳波)
Original Article

Abstract

Objective

Mahuang-Shigao herb-pair is a famous formula composed of Ephedra and Gypsum. The herb-pair is frequently used for treating cold symptoms and bronchial asthma in the clinical practice of Chinese medicine (CM). In the present study, we evaluated evidence for the benefit of combined use of Ephedra and Gypsum by analyzing the antipyretic and anti-asthmatic activities of Ephedra-Gypsum.

Methods

The antipyretic effects of Ephedra-Gypsum were evaluated in yeast-induced hyperthermia test. Thirty male Wistar rats were randomly divided into 5 groups, including control group, standard aspirin group, and 3 Ephedra- Gypsum groups of different doses (6, 12, 24 g/kg). Ephedra-Gypsum extract and asprin were administered orally 6 h after the injection of yeast solution and body temperature was measured every 1 h for 8 h. The antiasthmatic effects of Ephedra-Gypsum were evaluated using an ovalbumin (OVA)-induced asthmatic rat model. Thirty-six male SD rats were randomly divided into 6 groups. Rats were alternately sensitized and OVA+Al(OH) challenged by exposure to mists of ovalbumin. Ephedra-Gypsum extracts (6, 12, 24 g/kg) or dexamethasone were administered 45 min prior to the allergen challenge for 8 days. Latent period and the weight of wet to dry ratio of lung were determined. In addition, the eosinophils in blood and white blood cell (WBC) were counted by an YZ-Hemavet Analyzer.

Results

The Ephedra-Gypsum extracts at test dose (6, 12, 24 g/kg) significantly and dose-dependently attenuated yeast-induced fever in rats. The Ephedra-Gypsum extracts also prolonged the latent period, reduced OVA-induced increases in eosinophils and WBC, and decreased the wet and dry weight ratio of the lungs in the anti-asthmatic test.

Conclusions

These findings indicate that the Ephedra-Gypsum extract has antipyretic and anti-asthmatic properties. Hence, the results support additional scientific evidence in prescriptions.

Keywords

Ephedra-Gypsum herb-pair antipyretic effect anti-asthmatic activity Chinese medicine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wang S, Hu Y, Tan W, Wu X, Chen R, Cao J, et al. Compatibility art of traditional Chinese medicine: from the perspective of herb pairs. J Ethnopharmacol 2012;143:412–423.CrossRefPubMedGoogle Scholar
  2. 2.
    Chinese Pharmacopoeia Commission. Pharmacopoeia of People's Republic of China. Beijing: China Medical Science Press; 2010:87-88, 300–301.Google Scholar
  3. 3.
    Krizevski R, Bar E, Shalit O, Sitrit Y, Ben-Shabat S, Lewinsohn E. Composition and stereochemistry of ephedrine alkaloids accumulation in Ephedra sinica Stapf. Phytochemistry 2010;71:895–903.CrossRefPubMedGoogle Scholar
  4. 4.
    Kimura K, Hikino H. Studies on the constituents of Ephedra. Determination of alkaloids in Ephedra. Pharm Bull 1957;5:300–305.PubMedGoogle Scholar
  5. 5.
    Lee MK, Cheng BW, Che CT, Hsieh DP. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Toxicol Sci 2000;56:424–430.CrossRefPubMedGoogle Scholar
  6. 6.
    Tseng YL, Hsu HR, Kuo FH, Shieh MH, Chang CF. Ephedrines in over-the-counter cold medicines and urine specimens collected during sport competitions. J Anal Toxicol 2003;27:359–365.CrossRefPubMedGoogle Scholar
  7. 7.
    Wang HD, Wang MW, Li XB. Evaluation of the antipyretic activity of Gypsum Fibrosum and its constituents. Asian J Tradit Med 2009;4:82–84.Google Scholar
  8. 8.
    Fu XJ, Song XX, Wei LB, Wang ZG. Study of the distribution patterns of the constituent herbs in classical Chinese medicine prescriptions treating respiratory disease by data mining methods. Chin J Integr Med 2013;19:621–628.CrossRefPubMedGoogle Scholar
  9. 9.
    Luo J, Zhu Q, Chen F, Li X, Chen Y. Simultaneous determination of ephedra alkaloids in traditional chinese medicines by high-performance liquid chromatography. Acta Chromatographica 2012;24:475–487.CrossRefGoogle Scholar
  10. 10.
    Vilela FC, Bitencourt AD, Cabral LD, Franqui LS, Soncini R, Giusti-Paiva A. Anti-inflammatory and antipyretic effects of Sonchus oleraceus in rats. J Ethnopharmacol 2010;127:737–741.CrossRefPubMedGoogle Scholar
  11. 11.
    Yao XJ, Yin JA, Xia YF, Wei ZF, Luo YB, Liu M, et al. Puerarin exerts antipyretic effect on lipopolysaccharide-induced fever in rats involving inhibition of pyrogen production from macrophages. J Ethnopharmacol 2012;141:322–330.CrossRefPubMedGoogle Scholar
  12. 12.
    Eissa AA, Farag NA, Soliman GA. Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents. Bioorg Med Chem 2009;17:5059–5070.CrossRefPubMedGoogle Scholar
  13. 13.
    Wani TA, Chandrashekara HH, Kumar D, Prasad R, Sardar KK, Tandan SK. Anti-inflammatory and antipyretic activities of the ethanolic extract of Shorea robusta Gaertn. f. resin. Indian J Biochem Biophys 2012;49:463–467.PubMedGoogle Scholar
  14. 14.
    Hylkema MN, Hoekstra MO, Luinge M, Timens W. The strength of the OVA-induced airway inflammation in rats is strain dependent. Clin Exp Immunol 2002;129:390–396.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Jin M, Yang JH, Lee E, Lu Y, Kwon S, Son KH, et al. Antiasthmatic activity of luteolin-7-O-glucoside from Ailanthus altissima through the downregulation of T helper 2 cytokine expression and inhibition of prostaglandin E2 production in an ovalbumin-induced asthma model. Biol Pharm Bull 2009;32:1500–1503.CrossRefPubMedGoogle Scholar
  16. 16.
    Liu ZC, Zhang YF. Establishment of a rat chronic asthma model and its evaluation. Acta Pharm Sin (Chin) 2010;45:718–723.Google Scholar
  17. 17.
    Hoffler U, Oette K. Comparative studies on four thrombocyte counting methods: counting in the smear preparation after Fonio, chamber counting in the phase contrast microscope, counting with the Coulter Thrombocounter, and the Technicon Auto-Counter. Z Klin Chem Klin Biochem 1974;12:198–206.PubMedGoogle Scholar
  18. 18.
    Kim HJ, Lee HJ, Jeong SJ, Kim SH, Park EJ. Cortex Mori Radicis extract exerts antiasthmatic effects via enhancement of CD4(+)CD25(+)Foxp3(+) regulatory T cells and inhibition of Th2 cytokines in a mouse asthma model. J Ethnopharmacol 2011;138:40–46.CrossRefPubMedGoogle Scholar
  19. 19.
    Seo JW, Cho SC, Park SJ, Lee EJ, Lee JH, Han SS, et al. 1'-Acetoxychavicol acetate isolated from Alpinia galanga ameliorates ovalbumin-induced asthma in mice. PLoS One 2013;8:e56447.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Chu SJ, Huang KL, Wu SY, Ko FC, Wu GC, Li RY, et al. Systemic administration of FC-77 dampens ischemiareperfusion-induced acute lung injury in rats. Inflammation 2013.Google Scholar
  21. 21.
    Gao X, Guo M, Zhao B, Peng L, Su J, Bai X, et al. A urinary metabonomics study on biochemical changes in yeast-induced pyrexia rats: A new approach to elucidating the biochemical basis of the febrile response. Chem Biol Interact 2013;204:39–48.CrossRefPubMedGoogle Scholar
  22. 22.
    Hu Y, Liu P, Li HC, Wang YD. The "time-window" effect of early allergen exposure on a rat asthma model. Chin Med J 2013;126:2265–2269.PubMedGoogle Scholar
  23. 23.
    Hong ML, Song Y, Li XM. Effects and mechanisms of actions of Chinese herbal medicines for asthma. Chin J Integr Med 2011;17:483–491.CrossRefPubMedGoogle Scholar
  24. 24.
    Sakai-Kashiwabara M, Asano K. Inhibitory action of quercetin on eosinophil activation in vitro. Evid Based Complement Alternat Med 2013;2013:127105.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Fen Mei (梅 芬)
    • 1
  • Xue-feng Xing (邢学锋)
    • 1
  • Qing-fa Tang (汤庆发)
    • 1
  • Fei-long Chen (陈飞龙)
    • 1
  • Yang Guo (郭 阳)
    • 1
  • Shuai Song (宋 帅)
    • 1
  • Xiao-mei Tan (谭晓梅)
    • 1
  • Jia-bo Luo (罗佳波)
    • 1
  1. 1.School of Chinese Medical Sciences, Guangdong Province Key Laboratory of Chinese Medicine PharmaceuticsSouthern Medical UniversityGuangzhouChina

Personalised recommendations